March 23, 2023

Cognito gets $73m and hopes to do better this time

March 23, 2023

Merkel cell provides Incyte’s laggard a way in

March 22, 2023

89Bio Enlivened by Nash success

The company follows Madrigal and Akero with a clinical hit.

March 22, 2023

Roche and Lilly Eapp into Alzheimer’s testing

March 22, 2023

Second pivotal hit brings Claudin18.2 closer to approval

March 21, 2023

Obesity dropouts hurt Altimmune

The company’s value is cut in half as mid-stage data prove a let-down.

March 21, 2023

Mereo’s regulatory boost means little without a partner

March 20, 2023

Pear sets out its stall for potential sale

March 17, 2023

Bad vibes continue for Merck